| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $299.3M | +8.3% |
| Cost of Revenue | $76.9M | +7.0% |
| Gross Profit | $222.3M | +8.8% |
| R&D Expense | $97.6M | +8.2% |
| SG&A Expense | $63.9M | +16.3% |
| Pre-tax Income | -$92.5M | -3.9% |
| Income Tax | $1.8M | +41.1% |
| Net Income | -$94.3M | -4.4% |
| EPS (Basic) | -$0.76 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $171.7M | -30.9% |
| Short-term Investments | $69.4M | -6.1% |
| Accounts Receivable | $26.3M | -10.7% |
| Current Assets | $303.6M | -20.1% |
| Total Assets | $445.9M | +2.8% |
| Current Liabilities | $144.5M | +9.2% |
| Total Liabilities | $149.4M | +7.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $18.5M | -27.8% |
| Capital Expenditures | $1.7M | +34.9% |
| Investing Cash Flow | -$75.4M | -908.9% |
| Financing Cash Flow | -$19.9M | -304.0% |
| Free Cash Flow | $16.8M | -31.1% |
| +1.3% |
| EPS (Diluted) | -$0.76 | +1.3% |
| Stockholders' Equity |
| $296.6M |
| +0.6% |